⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

263.81USD

-3.8000 (-1.42%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on JNJ.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End09/2026 Q3
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 263.81
P/E39.5
Dvd Ind Yld2.0%
P/B7.79
P/S6.4
Curr EV/T12M EBITDA25.9
Mkt Cap (USD)635.1B
Curr EV (USD)662.5B
2)

Per Share Data

EPS T12M6.61
DPS5.36
Bk Val Per Sh33.87
Rev/Sh40.57
Cash/Sh7.16
Curr Shares Out2,407.3M
FCF/Sh8.41
3)

Cash Flow Analysis

P/CF24.3
Curr P/FCF30.8
CF/NI1.6
Dvd P/O80.1%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales26.3%
Eff Interest Rate2.2%
4)

Growth Potential

Dil EPS 1Y Gr90.5%
Cap 1Y Gr19.7%
BPS 1Y Gr14.1%
R&D To Sales0.1%
Retention Rate19.9%
Rev 1Y Gr6.0%
FCF 1Y Gr-0.7%
Assets 1Y Gr10.6%
5)

Profitability

EBITDA25.5B
EBIT21.8B
Operating Margin21.9%
Pretax Margin17.9%
Net Margin16.2%
ROA8.2%
ROE20.0%
ROC15.7%
Asset Turnover0.51
6)

Structure

Current Ratio1.02
Quick Ratio0.65
Debt/Assets22.6%
Debt/Com Eq54.8%
Net Debt/EBITDA1.09
Tot Debt/Capital35.4%
Gross Margin67.6%
EBIT/Int Exp22.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.